US FDA Approves Revolutionary Postpartum Depression Pill – Zurzuvae Offers Hope for New Mothers
In a historic breakthrough, the Food and Drug Administration (FDA) in the US has granted approval for the first-ever pill designed to combat postpartum depression (PPD). Marketed under the name Zurzuvae, the innovative zuranolone pill provides a convenient once-daily dosage regimen over a two-week period. Previously, PPD treatment options were limited to intravenous injections, but … Read more
